Canton Strategic Holdings (CNTN) Share-based Compensation (QoQ) (2021 - 2026)
Canton Strategic Holdings (CNTN) Share-based Compensation (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,586.64% |
| Dec 31, 2025 | -748.66% |
| Sep 30, 2025 | -64.77% |
| Jun 30, 2025 | 158.98% |
| Mar 31, 2025 | 3.83% |
| Dec 31, 2024 | 9.98% |
| Sep 30, 2024 | 24.92% |
| Jun 30, 2024 | 0.02% |
| Mar 31, 2024 | -73.60% |
| Dec 31, 2023 | 268.36% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -54.25% |
| Mar 31, 2023 | 169.27% |
| Dec 31, 2022 | -307.13% |
| Sep 30, 2022 | -28.88% |
| Jun 30, 2022 | 1,646.82% |
| Mar 31, 2022 | 187.47% |
| Dec 31, 2021 | 52.02% |
| Sep 30, 2021 | -99.20% |
| Jun 30, 2021 | -17.81% |